Loading. Please wait...

The International Lung Cancer Summit 2020

Full Event

For single sessions, please scroll down

The power of social media in Oncology: what we can learn from our virtual peers

Gil Morgan, MD

Treatment standards in non-oncogene addicted NSCLC before COVID19

Maurice Pérol, MD

How can we treat patients with lung cancer during the SARS-CoV-2 pandemic?

Giuseppe Banna, MD

COVID19 & lung cancer: treatment & outcomes from a Spanish cohort

Antonio Calles, MD

Radiotherapy in lung cancer during the COVID-19 era

André Durham, MD-PhD

Mesothelioma: new therapeutic strategies and future perspectives for a difficult disease with a heavy social burden

Alessandra Curioni-Fontecedro, MD-PhD

Small cell lung cancer (SCLC): Treatment challenges and a glimpse into the development of new targets

Stephen V. Liu, MD

Personalized Medicine with IO: can we tailor immunotherapy options to patients?

Joshua Bauml, MD

Actionable mutations on the horizon: up and coming agents in targeted therapies

Christian Rolfo, MD-PhD

Tailoring targeted therapies: what TKI is suitable for what patient?

Howard (Jack) West, MD

Integrating immunotherapy into localized NSCLC

Sandip P. Patel, MD

Virtual Booth Section

We thank all our partners for their ongoing support with the
International Lung Cancer Summit

© 2020 International Lung Cancer Summit • info@lungcancersummit.org 

• PEAK Medicals GmbH in collaboration with Hôpitaux Universitaires de Genève (HUG) & Centre hospitalier universitaire vaudois (CHUV)

Breitensteinstrasse 31 • 8037 Zurich • Switzerland •